Pars plana implant and vitrectomy for treatment of neovascular glaucoma.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 8594629.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To evaluate the effectiveness of pars plana implants in the treatment of neovascular glaucoma. Twenty-two consecutive pars plana implant procedures performed for neovascular glaucoma were retrospectively reviewed. Preoperative intraocular pressures ranged from 22 to 80 mmHg (mean 46 mmHg) on a mean of three glaucoma medications. With a mean follow-up interval of 16 months, final postoperative intraocular pressures ranged 9-21 mmHg (mean 16) on a mean 0.7 medications. One patient required a second implant to achieve final intraocular pressure control. Visual acuity was stabilized or improved in 19 of 22 cases (86%). Complications included retinal detachment in two cases (9%). Macular pucker, vitreous hemorrhage, hyphema, choroidal hemorrhage, diplopia, and loss of light perception occurred in one case (5%) each. None developed phthisis bulbi. Pars plana drainage tube implants are effective in the treatment of neovascular glaucoma.
Medical subject headings
- Anterior Eye Segment
- Glaucoma, Neovascular
- Molteno Implants
- Vitrectomy